跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 516 条关于
“Hypoparathyroidism”
全部
516
临床试验
470
药物
4
机构
0
资讯
42
去年
Ascendis Pharma's Yorvipath Commercially Available in the US, Offering New Hope for Hypoparathyroidism
4个月前
Palopegteriparatide Shows Sustained 3-Year Benefits in Hypoparathyroidism Treatment
去年
TransCon PTH Shows Sustained 4-Year Efficacy in Hypoparathyroidism Patients
15天前
Canada's Drug Agency Recommends Conditional Reimbursement for Yorvipath in Chronic Hypoparathyroidism
去年
AstraZeneca's Eneboparatide Meets Primary Endpoint in Phase III Trial for Hypoparathyroidism
去年
MBX Biosciences Completes Enrollment in Phase 2 Trial of Canvuparatide for Hypoparathyroidism
去年
MBX Biosciences Strengthens Leadership with Endocrinology Expert to Advance Hypoparathyroidism Treatment
去年
BridgeBio's Encaleret Achieves Calcium Normalization in 80% of Post-Surgical Hypoparathyroidism Patients
10个月前
TransCon PTH Shows Sustained Kidney Function Improvements in 3-Year Hypoparathyroidism Study
2年前
Error parsing response
第 1 页,共 5 页
上一页
下一页